Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bradsher Neal C
Relationship:   10% Owner
City:   Union City
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   129,185    

Indirect Shares

   57,363,752      
Direct Value   $1,186,888    

Indirect Value

   $499,113,789      
Total Shares   57,492,937      
Total Value   $500,300,677      


Lineage Cell Therapeutics Ord Shs $80,609 Comarco Inc $318 STAAR Surgical Co $1,105,930 Oncocyte Corp $31 Lineage Cell Therapeutics Ord Shs $80,609 Comarco Inc $318 STAAR Surgical Co $1,105,930 Oncocyte Corp $31
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    60   
    50    

     Stock price went up :
    44   
    16    
     Stock price went down :
    16   
    34    
   
     Gain/Loss Ratio :
   2.8   
   2.8   
     Percentage Gain/Loss :
   10.9%
 -929.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Questcor Pharmaceuticals Inc QCOR Director 2014-08-14 0 2014-08-14 0    Premium*  
            Lineage Cell Therapeutics Ord Shs LCTX Director, 10% Owner 2024-02-06 87,628 2024-02-06 41,666,255    Premium*  
            Comarco Inc CMRO 10% Owner 2017-09-15 15,500 2017-09-15 0    Premium*  
            STAAR Surgical Co STAA 10% Owner 2024-05-09 25,900 2024-05-09 10,768,431    Premium*  
            Palomar Medical Technologies Inc PMTI 10% Owner 2013-06-24 0 2013-06-24 0    Premium*  
            Asterias Biotherapeutics Inc AST See Remarks Below 2019-03-08 0 2019-03-08 0    Premium*  
            Oncocyte Corp OCX 10% Owner 2024-04-11 157 2024-04-11 4,929,066    Premium*  
* Premium Members only  

Records found :    612         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 25
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LCTX Lineage Cell Therapeutics... Director   –       •       •   2016-06-21 4 B $0.00 $0 I/I 0 24,897,032 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2016-06-21 4 B $2.39 $6,531,000 D/D 2,732,636 24,897,032 3.92 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2017-02-15 4 B $2.70 $5,999,999 D/D 2,222,222 27,119,254 3.92 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2017-02-15 4 B $0.00 $0 I/I 0 27,119,254 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2017-07-31 4 B $0.00 $0 I/I 0 27,269,254 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2017-07-31 4 B $2.80 $420,000 D/D 150,000 27,269,254 3.92 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2017-10-13 4 B $0.00 $0 I/I 0 29,971,561 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2017-10-13 4 B $2.60 $6,999,998 D/D 2,692,307 29,971,561 3.92 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-03-08 4 A $0.00 $0 I/I 0 33,728,991 0 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-03-08 4 A $0.00 $0 D/D 3,757,430 33,728,991 0 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-04-16 4 A $0.00 $0 I/I 0 33,980,826 0 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-04-16 4 A $1.32 $332,397 D/D 251,835 33,980,826 0 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-08-13 4 B $0.00 $0 I/I 0 33,990,826 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-08-13 4 B $0.99 $9,949 D/D 10,000 33,990,826 3.84 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-08-14 4 B $0.98 $1,379 D/D 1,407 33,992,233 3.84 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-08-14 4 B $0.00 $0 I/I 0 33,992,233 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-08-15 4 B $0.00 $0 I/I 0 34,005,379 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2019-08-15 4 B $0.97 $12,717 D/D 13,146 34,005,379 3.92 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2021-06-25 4 OE $2.20 $54,384 D/D 24,720 87,628 0 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2022-03-23 4 B $0.00 $0 I/I 0 34,265,485 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2022-03-23 4 B $1.37 $355,305 D/D 260,106 34,265,485 3.92 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2022-03-24 4 B $1.42 $284,340 D/D 200,000 34,465,485 3.92 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2022-03-24 4 B $0.00 $0 I/I 0 34,465,485 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2022-03-25 4 B $0.00 $0 I/I 0 34,935,485 2.17 -
LCTX Lineage Cell Therapeutics... Director   –       •       •   2022-03-25 4 B $1.44 $678,022 D/D 470,000 34,935,485 3.92 -
  612  Records found
  1   2   3   4   5   6   7   8  9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25      
  Page 8 of 25  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us